Delivery Order SPE2DB20D1110-SPE2DB25FK29W
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. The contract, awarded on August 18, 2025, carries a ceiling value of $2,029.15 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This was a competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a common medication used to treat benign prostatic hyperplasia. This firm fixed-price delivery order, valued at $11,771.03, is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procedures with no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,041.28 for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of June 5, 2025. Performance of this order is based in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,073.32 and an ultimate completion date of September 5, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract is firm fixed price with a ceiling value of $10,078.41 and an ultimate completion date of August 15, 2025. This is a non-set-aside competitive award, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a common medication used to treat benign prostatic hyperplasia. This firm fixed-price contract, valued at $3,523.52, was competitively awarded with no set-aside designation and is scheduled for completion by September 29, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg on August 8, 2025, with a ceiling value of $3,668.31 and an ultimate completion date of August 11, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. Tamsulosin is a commonly used medication for benign prostatic hyperplasia, and...
- The Defense Logistics Agency awarded a delivery order valued at $3,379.76 to AmerisourceBergen Drug Corp for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 units). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 14, 2025. The award represents procurement of a generic medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia, supporting the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. This firm fixed-price delivery order, valued at $24,171.55, is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $2,702.16. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...